Avivagen Inc VIVXF

Healthcare

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.

GREY:VIVXF - Post by User

Avivagen Inc

<< Previous

Bullboard Posts

Next >>

Post by DrJayseron Jan 29, 2021 12:47pm

180 Views

Post# 32421073

28,000$ sales out of a 10B$ industry , room to grow ;-)

"We've been working closely with the Avivagen team to launch the first Dr Tobias branded product into the companion pet market in the United States. With an ever-expanding companion pet market, we believe that our existing Dr Tobias customers will embrace the opportunity to provide the same high standards in supplements and vitamins to their dogs," said Dave Kohler, CEO of Mimi's Rock Corp.

"We're very excited to bring our high quality supplement for companion animals to this important and growing $10 billion per year market," says Kym Anthony, Chief Executive Officer, Avivagen Inc. "We believe the combination of Avivagen's OxC-betaTM technology with Mimi's Rock's expertise in online sales and customer service is a win-win scenario for both enterprises, and look forward to building upon this partnership."